Event Type
Disclosure
Mandatory
Variant
8-K
Entry into a Material Definitive Agreement On December 30, 2025, KALA BIO, Inc. (the “Company”) entered into a settlement agreement with Baker Bros. Advisors LP
Unregistered Sales of Equity Securities On December 30, 2025, the Company issued an aggregate of 4,600,000 shares of Common Stock in private, unregistered trans
and Exhibit 99.1 shall not be deemed “filed” for purposes of the Securities Exchange Act of 1934, as amended, nor shall it be deemed incorporated by reference i
Financial Statements and Exhibits (d) Exhibits Exhibit No. Description 10.1 Settlement Agreement and Mutual Release, dated December 30, 2025, by and between KAL